Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

Stem Cell Res Ther. 2021 Apr 27;12(1):250. doi: 10.1186/s13287-021-02281-1.

C Eguizabal^{1

2}, L Herrera^{3

4}, M Inglés-Ferrándiz^{3

4}, J C Izpisua Belmonte⁵

¹ Cell Therapy, Stem Cells and Tissues Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. CRISTINA.EGUIZABALARGAIZ@osakidetza.eus.
² Research Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain. CRISTINA.EGUIZABALARGAIZ@osakidetza.eus.
³ Cell Therapy, Stem Cells and Tissues Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
⁴ Research Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.
⁵ Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California, 93027, USA.

No abstract available

Publication types